Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02CYL
|
||||
Former ID |
DIB010464
|
||||
Drug Name |
MOR-208
|
||||
Synonyms |
XmAb CD19; XENP-5574; XENP-5603; XmAb-5574; Anti-CD19 humanized mAb (cancer/autoimmune disease), Xencor; Anti-CD19 humanized monoclonal antibody (cancer/autoimmune disease), Xencor
|
||||
Drug Type |
Antibody
|
||||
Indication | Autoimmune diabetes [ICD10:E08-E13] | Phase 2 | [524052] | ||
Company |
Morphosys
|
||||
Target and Pathway | |||||
Target(s) | B-lymphocyte antigen CD19 | Target Info | [532984] | ||
NetPath Pathway | IL-7 Signaling Pathway | ||||
PANTHER Pathway | B cell activation | ||||
Pathway Interaction Database | BCR signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.